Siga Technologies Inc
- Last sale
- Nov 12, 2026 · -7.32%
- Market cap
- $209.10M
- 71.86M shares
- Filings
- 1,004
Q3 2026−31.8% FY25 yoy
Q3 2026−60.7% FY25 yoy
Q3 2026−66.1% FY25 yoy
FY 2019derivedN/M FY19 yoy
Q3 2026−61.0% FY25 yoy
Q3 2026−0.3% FY25 yoy
- $209.10M
- 304.7×
- 4.0×
- 1.3×
- —
- 20.76%
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $94,574,902 | reported | |
| FY 2024 | 2024-12-31 | $138,719,350 | reported | |
| FY 2023 | 2023-12-31 | $139,917,220 | reported | |
| FY 2022 | 2022-12-31 | $110,775,610 | reported | |
| FY 2021 | 2021-12-31 | $133,670,454 | reported | |
| FY 2020 | 2020-12-31 | $124,959,304 | reported | |
| FY 2019 | 2019-12-31 | $26,742,085 | reported | |
| FY 2018 | 2018-12-31 | $477,053,782 | reported | |
| FY 2017 | 2017-12-31 | $12,268,960 | reported | |
| FY 2016 | 2016-12-31 | $14,987,628 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $43.12M | $0.00 | $43.12M | $0.60 | 71.64M sh | +0.3% | — |
| FY2024 | $42.67M | $0.00 | $42.67M | $0.60 | 71.44M sh | +0.5% | — |
| FY2023 | $32.14M | $11.07M | $43.21M | $0.45 | 71.09M sh | −1.5% | — |
| FY2022 | $32.94M | $13.01M | $45.95M | $0.45 | 72.20M sh | −1.1% | — |
| FY2021 | $0.00 | $26.02M | $26.02M | — | 73.03M sh | −4.8% | — |
Segments
LineFY2025ShareChange
UNITED STATES$88.75M94%−23.3%
CANADA$5.82M6.2%+689.1%
Non-US$5.82M6.2%−74.7%
Asia Pacific$0.00—−100.0%
EMEA$0.00—−100.0%
Other———
Total$94.57M
Pharmaceutical preparations
Siga Technologies Inc is the 103rd largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
URGNUroGen Pharma Ltd.$109.8M21.4%139.8%$1.3BZVRAZevra Therapeutics, Inc.$106.5M350.9%78.2%$663.8MZYMEZymeworks Inc.$106.0M38.9%76.6%$1.8B
SIGASiga Technologies Inc (this company)$94.6M31.8%24.6%$209.1M
CYTKCytokinetics Inc$88.0M376.6%891.6%$7.8BLABStandard Biotools Inc.$85.3M6.2%87.8%$257.9MSPRYARS Pharmaceuticals, Inc.$84.3M5.5%203.3%$382.5MNRIXNurix Therapeutics, Inc.$84.0M54.0%314.9%$2.7BARCTArcturus Therapeutics Holdings Inc.$82.0M46.1%80.2%$298.7MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Siga Technologies Inc · CIK 1010086 · Engraved from SEC EDGAR